Again, as for the tumor growth rate, this effect was significantly reverted by the S1P2-agonist CYM5520, and on the other hand, there was no significant difference when mice where treated with both SR59230A and ABC294640 compared to SR59230A alone (Fig. 6c). Here, S1PR2 is linked to neoplasm.